2,5 Dibromo-n-(2-chloroethyl)-n-methyl benzene sulfonamide → HCID 178484206, Verbindung
Reaktionsgleichung
[Br:1][C:2]1[CH:7]=[CH:6][C:5]([Br:8])=[CH:4][C:3]=1[S:9]([N:12]([CH2:14][CH2:15]Cl)[CH3:13])(=[O:11])=[O:10].[F:17][C:18]1[CH:32]=[CH:31][C:21]2[NH:22][C:23]([CH:25]3[CH2:30][CH2:29][NH:28][CH2:27][CH2:26]3)=[N:24][C:20]=2[CH:19]=1>>[Br:1][C:2]1[CH:7]=[CH:6][C:5]([Br:8])=[CH:4][C:3]=1[S:9]([N:12]([CH2:14][CH2:15][N:28]1[CH2:27][CH2:26][CH:25]([C:23]2[NH:22][C:21]3[CH:31]=[CH:32][C:18]([F:17])=[CH:19][C:20]=3[N:24]=2)[CH2:30][CH2:29]1)[CH3:13])(=[O:11])=[O:10]Komponenten
3
Versuchsvorschrift
The title compound was prepared using the procedure described in Example 1 using 2,5-Dibromo-N-(2-chloroethyl)-N-methyl benzene sulfonamide (D10) and 4-(5-fluoro 1H benzimidazol-2-yl)piperidine (D17). MH+ 5731575/577.
Quellen und Nachweise
- ORD-Eintrag
- ord-5449e3ef1a6046ab95fcf2542efa594f
- Quelldatensatz
- uspto-grants-2003_12